The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05590403
Brief Title: A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above

First Submitted : October 18, 2022
First Submitted that Met QC Criteria : October 18, 2022
First Posted : October 21, 2022

Last Update Submitted that Met QC Criteria : March 6, 2024
Last Update Posted : March 7, 2024